Neuphoria Therapeutics Inc. (NEUP)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Lynx1 Capital Management Weston Nichols | 875,328 | $3,562,585 | +1% | 0.56% |
| 2. | Shay Capital Samuel Ginzburg | 151,010 | $614,611 | -11% | 0.05% |
| 3. | Balyasny Asset Management Dmitry Balyasny | 142,183 | $578,685 | 0% | |
| 4. | Squadron Capital Management William Blank | 76,728 | $312,283 | 0.11% | |
| 5. | Ikarian Capital Neil Shahrestani | 47,443 | $193,093 | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.14 | 639,110 | $3,283,108.07 | 875,328 | 2025-10-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 155,367 | $632,344 | 0.12% | |
| 2. | 98,516 | $400,960 | 0% | |
| 3. | 52,007 | $211,668 | 0% | |
| 4. | 33,589 | $136,707 | 0% | |
| 5. | 14,000 | $56,980 | 0% |
Hedge Fund Resource Center